Cognitive Decline Starts Decades Before Symptoms

Dementia and Alzheimer’s are cruel diseases, usually associated with older patients. However, cognitive decline is not a normal part of aging. The changes in brain metabolism, inflammation, and detox pathways, that can lead to cognitive decline, begin far earlier.

Those with familial Alzheimer’s disease show abnormal brain glucose metabolism up to 18 years before symptoms begin, and measurable brain atrophy 13 years before any clinical signs appear.

This article will explore how TruAge epigenetic markers, homocysteine, omega-3 index, and mitochondrial testing can detect cognitive decline risks.

What drives early cognitive decline?

At its core, cognitive decline is a metabolic issue. When your brain cells can’t produce or access enough energy, often due to insulin resistance, mitochondrial dysfunction, or poor nutrient status, they start to struggle. Over time, this leads to inflammation, impaired neurotransmitter production, and eventually, neurodegeneration.

Here are just a few of the factors that contribute:

High homocysteine – Elevated homocysteine levels are linked to increased risk of dementia and vascular damage. This amino acid becomes toxic in excess and is often a sign of B vitamin deficiency or poor methylation.
Low omega-3 index – DHA and EPA, found in fatty fish and high-quality supplements, are essential for brain structure and anti-inflammatory signalling. A low omega-3 index is a known risk factor for cognitive decline.
Mitochondrial dysfunction – Your brain consumes a disproportionate amount of your body’s energy. When mitochondria (the powerhouses of your cells) aren’t working well, neurons can’t function properly, and long-term damage follows.
Toxic burden – Impaired detox pathways can lead to a build-up of neurotoxic compounds, which further strain brain function and promote inflammation.

These imbalances often go unnoticed in standard blood work, but they can be picked up with functional testing long before symptoms emerge.

TruAge: Measuring the real risk

Rather than waiting for signs of decline to appear, TruAge measures epigenetic markers that reveal how fast you’re aging at a cellular level, including in your brain. If your biological age is outpacing your chronological one, it’s a sign that underlying stressors, e.g. inflammation or metabolic dysfunction, may already be at play.

TruAge doesn’t just give you a number. It offers a detailed insight into how lifestyle, environment, and genetics are shaping your future health, giving you time to intervene and change the trajectory if needed.

Alongside TruAge, Dr Grosser uses a targeted suite of functional tests to evaluate brain-related risks in more depth. These include tests for identifying methylation or B-vitamin issues, Omega-3 Index testing, mitochondrial health panels and nutritional assessments.

Together, these tools create a comprehensive map of your brain’s resilience and highlight areas where intervention could protect against decline.

A preventive, personalised approach

As the only Functional Medicine Certified Interventional Cardiologist in the UK and Europe, Dr Konrad Grosser combines advanced cardiovascular care with deep-rooted expertise in metabolic and neurological health. He understands that cognitive decline is rarely the result of a single issue, it’s the accumulation of small imbalances, lifestyle stressors, and genetic tendencies.

That’s why his approach focuses on early testing, personalised strategies, and root-cause resolution, long before the first symptom appears.

If you’re concerned about your cognitive health or simply want to stay sharp for the years ahead, now is the time to act. Book your TruAge cognitive health assessment with Dr Grosser today.